Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients

IntroductionPrevious studies have shown a reduction in the effectiveness of primary COVID-19 vaccination in patients with rheumatic diseases. However, limited data is available regarding the effectiveness of the COVID-19 vaccine booster dose, especially on cellular response. The study aimed to asses...

Full description

Bibliographic Details
Main Authors: Jakub Wroński, Bożena Jaszczyk, Leszek Roszkowski, Anna Felis-Giemza, Krzysztof Bonek, Anna Kornatka, Magdalena Plebańczyk, Tomasz Burakowski, Barbara Lisowska, Brygida Kwiatkowska, Włodzimierz Maśliński, Małgorzata Wisłowska, Magdalena Massalska, Marzena Ciechomska, Ewa Kuca-Warnawin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
COVID-19
booster vaccine
arthritis
immunogenicity
cellular response
humoral response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033804/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1033804/full

Similar Items